$ROIV

$37.33▲ +1.6% YTD

4 SEC 13D/G filings tracked · Last updated Aug 27, 2026

Filing History

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV ROIVW - Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S…

News

ROIV ▲ +1.6% - Roivant Sciences Ltd.

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV ROIVW - Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S…

News

ROIV ▲ +1.6% - Roivant Sciences Ltd.

CP $37.33▲ +1.6%Aug 27, 2026 · ThinkSabio Blog

$ROIV highs continue off FDA earlier release…

SEC 13D/G

ROIV - Roivant Sciences Ltd. - SEC Filing Update (13-AUG-2026) | ThinkSabio - Stocks Simplified

$36.28▲ 65.51%Aug 13, 2026 · ThinkSabio Blog

$ROIV SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ROIV Roivant Sciences Ltd. : $36.28 Sector: Healthcare | YTD: 🔼…